您的位置: 首页 > 农业专利 > 详情页

FUSED PENTACYCLIC IMIDAZOLE DERIVATIVES
专利权人:
UCB BIOPHARMA SPRL;SANOFI SA
发明人:
DE HARO GARCIA TERESA,DELIGNY MICHAEL,HEER JAG PAUL,QUINCEY JOANNA RACHEL,XUAN MENGYANG,ZHU ZHAONING,BROOKINGS DANIEL CHRISTOPHER,CALMIANO MARK DANIEL,EVRARD YVES,HUTCHINGS MARTIN CLIVE,JOHNSON JAMES
申请号:
AP201709809
公开号:
AP201709809A0
申请日:
2015.10.02
申请国别(地区):
AP
年份:
2017
代理人:
摘要:
A series of fused pentacyclic imidazole derivatives, being potent modulators of human TNFa activity, are accordingly of benefit in the treatment and/or prevention of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders. In particular, the present invention is concerned with 6,7-dihydro-7,14-methanobenzimidazo[1,2-b][2,5]benzodiazocin-5(14H)-one derivatives and analogs thereof.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充